Related Experiment Videos
Reactive thrombocytosis without endothelial damage does not affect the microvascular anastomotic patency
Yur-Ren Kuo1, Kuender D Yang, Mong-Na Lo Huang
1Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital at Kaohsiung, Taiwan.
Annals of Plastic Surgery
|January 25, 2003
Summary
Reactive thrombocytosis alone does not increase thrombosis risk in microvascular anastomosis. Meticulous surgical technique, preventing platelet activation, is crucial for maintaining vessel patency and preventing thrombosis.
Area of Science:
- Vascular Surgery
- Hematology
- Thrombosis Research
Background:
- Controversy exists regarding the link between thrombocytosis and thrombosis complications.
- Understanding the role of reactive thrombocytosis in microvascular anastomosis is essential.
Purpose of the Study:
- To investigate if reactive thrombocytosis, with or without endothelial damage, impacts microvascular anastomosis patency.
- To determine the primary factors influencing thrombosis in microsurgical anastomoses.
Main Methods:
- Utilized a rodent splenectomy-induced thrombocytosis model and a thrombogenic endothelial damage model.
- Compared four groups: sham operation (with/without anastomosis), thrombocytosis (with/without anastomosis), assessing vascular patency and platelet activation (CD62P).
Main Results:
- Reactive thrombocytosis alone did not significantly affect patency rates or platelet activation without endothelial damage.
- Thrombogenic anastomosis significantly increased CD62P expression, decreased perfusion, and reduced patency rates in both control and thrombocytosis groups.
- No significant difference in patency or perfusion was observed between thrombocytosis and control groups when the anastomosis was not thrombogenic.
Conclusions:
- Microvascular anastomosis can be safely performed in the presence of reactive thrombocytosis if the anastomosis itself is not thrombogenic.
- Meticulous surgical technique that avoids triggering platelet activation is the most critical factor in preventing thrombosis in microsurgical anastomoses.